ABLE Labs Raises $12 billion Series A

<strongThe company is currently finalizing a Series A financing round exceeding KRW 10 billion (approximately USD 6.8 million)</strong and is conducting a proof-of-concept (PoC) project with a major U.S. ABLE Labs. Company Profile & Funding. ABLE Labs is to contribute improve human health by providing bio automated solutions.

What it does

<strongThe company is currently finalizing a Series A financing round exceeding KRW 10 billion (approximately USD 6.8 million)</strong and is conducting a proof-of-concept (PoC) project with a major U.S. ABLE Labs. Company Profile & Funding. ABLE Labs is to contribute improve human health by providing bio automated solutions.

Traction

Big Pharma PoC this year < ENGLISH NEWS < 기사본문 - 더바이오 participated in the latest tracked round; deeper traction analysis is held until source support is strong enough.

Trend impact

MD-grade thesis held: available source material is not specific enough to support a non-generic investor-economist read without overclaiming.

Funding history

• August 31, 2026 · Series A · $12 billion · Big Pharma PoC this year < ENGLISH NEWS < 기사본문 - 더바이오